First Bankers Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.36M | Buy |
37,181
+5,690
| +18% | +$1.22M | 2.91% | 4 |
|
|
2026
Q1 | $6.85M | Buy |
31,491
+111
| +0.4% | +$24.6K | 2.31% | 9 |
|
|
2025
Q4 | $7.17M | Buy |
31,380
+112
| +0.4% | +$25.5K | 2.41% | 7 |
|
|
2025
Q3 | $7.24M | Sell |
31,268
-1,141
| -4% | -$232K | 2.52% | 4 |
|
|
2025
Q2 | $6.02M | Buy |
32,409
+9,511
| +42% | +$1.77M | 2.23% | 7 |
|
|
2025
Q1 | $4.8M | Sell |
22,898
-51
| -0.2% | -$9.91K | 1.89% | 12 |
|
|
2024
Q4 | $4.08M | Sell |
22,949
-252
| -1% | -$46.3K | 1.59% | 14 |
|
|
2024
Q3 | $4.58M | Sell |
23,201
-573
| -2% | -$107K | 1.76% | 14 |
|
|
2024
Q2 | $4.08M | Buy |
23,774
+111
| +0.5% | +$18.4K | 1.68% | 16 |
|
|
2024
Q1 | $4.31M | Buy |
23,663
+17
| +0.1% | +$2.93K | 1.84% | 15 |
|
|
2023
Q4 | $3.66M | Sell |
23,646
-495
| -2% | -$72.2K | 1.7% | 17 |
|
|
2023
Q3 | $3.6M | Buy |
24,141
+14
| +0.1% | +$2.06K | 1.81% | 16 |
|
|
2023
Q2 | $3.25M | Sell |
24,127
-200
| -0.8% | -$29.3K | 1.59% | 17 |
|
|
2023
Q1 | $3.88M | Buy |
24,327
+286
| +1% | +$43.7K | 1.95% | 14 |
|
|
2022
Q4 | $3.88M | Sell |
24,041
-262
| -1% | -$40.2K | 2% | 16 |
|
|
2022
Q3 | $3.26M | Sell |
24,303
-1,011
| -4% | -$145K | 1.87% | 15 |
|
|
2022
Q2 | $3.88M | Sell |
25,314
-1,337
| -5% | -$204K | 2.03% | 14 |
|
|
2022
Q1 | $4.32M | Sell |
26,651
-2,903
| -10% | -$422K | 2.01% | 13 |
|
|
2021
Q4 | $4M | Sell |
29,554
-2,740
| -8% | -$324K | 1.76% | 15 |
|
|
2021
Q3 | $3.48M | Sell |
32,294
-2,615
| -7% | -$299K | 1.75% | 15 |
|
|
2021
Q2 | $3.93M | Sell |
34,909
-10,209
| -23% | -$1.15M | 1.91% | 12 |
|
|
2021
Q1 | $4.88M | Sell |
45,118
-5,435
| -11% | -$581K | 2.04% | 10 |
|
|
2020
Q4 | $5.42M | Buy |
50,553
+1,896
| +4% | +$182K | 2.09% | 8 |
|
|
2020
Q3 | $4.26M | Sell |
48,657
-1,601
| -3% | -$151K | 1.81% | 17 |
|
|
2020
Q2 | $4.93M | Sell |
50,258
-254
| -0.5% | -$22.4K | 2.21% | 7 |
|
|
2020
Q1 | $3.85M | Buy |
50,512
+528
| +1% | +$45K | 1.99% | 13 |
|
|
2019
Q4 | $4.43M | Buy |
49,984
+3,821
| +8% | +$317K | 1.87% | 15 |
|
|
2019
Q3 | $3.5M | Buy |
46,163
+2,016
| +5% | +$138K | 1.58% | 20 |
|
|
2019
Q2 | $3.21M | Buy |
44,147
+147
| +0.3% | +$11.6K | 1.48% | 22 |
|
|
2019
Q1 | $3.55M | Sell |
44,000
-42,734
| -49% | -$3.5M | 1.69% | 19 |
|
|
2018
Q4 | $8M | Buy |
86,734
+43,992
| +103% | +$3.87M | 2.08% | 12 |
|
|
2018
Q3 | $4.04M | Sell |
42,742
-11
| -0% | -$1.04K | 1.93% | 13 |
|
|
2018
Q2 | $3.96M | Buy |
42,753
+634
| +2% | +$61.9K | 2.06% | 10 |
|
|
2018
Q1 | $3.99M | Sell |
42,119
-1,386
| -3% | -$152K | 2.1% | 11 |
|
|
2017
Q4 | $4.21M | Sell |
43,505
-160
| -0.4% | -$15.1K | 2.08% | 13 |
|
|
2017
Q3 | $3.88M | Hold |
43,665
| – | – | 2.01% | 16 |
|
|
2017
Q2 | $3.17M | Sell |
43,665
-500
| -1% | -$33.6K | 1.71% | 20 |
|
|
2017
Q1 | $2.88M | Buy |
44,165
+500
| +1% | +$31.4K | 1.57% | 22 |
|
|
2016
Q4 | $2.73M | Sell |
43,665
-1,434
| -3% | -$87.5K | 1.52% | 21 |
|
|
2016
Q3 | $2.84M | Buy |
45,099
+260
| +0.6% | +$16.8K | 1.59% | 20 |
|
|
2016
Q2 | $2.78M | Sell |
44,839
-17,663
| -28% | -$1.08M | 1.54% | 20 |
|
|
2016
Q1 | $3.57M | Buy |
62,502
+1,425
| +2% | +$79.4K | 1.5% | 19 |
|
|
2015
Q4 | $3.62M | Buy |
61,077
+1,648
| +3% | +$94.9K | 1.58% | 21 |
|
|
2015
Q3 | $3.23M | Sell |
59,429
-325
| -0.5% | -$21.2K | 1.49% | 23 |
|
|
2015
Q2 | $4.01M | Sell |
59,754
-675
| -1% | -$44.1K | 1.7% | 15 |
|
|
2015
Q1 | $3.54M | Buy |
60,429
+3,070
| +5% | +$185K | 1.52% | 20 |
|
|
2014
Q4 | $3.75M | Buy |
57,359
+134
| +0.2% | +$8.45K | 1.63% | 17 |
|
|
2014
Q3 | $3.31M | Buy |
57,225
+2,318
| +4% | +$129K | 1.46% | 20 |
|
|
2014
Q2 | $3.1M | Sell |
54,907
-75
| -0.1% | -$3.94K | 1.36% | 21 |
|
|
2014
Q1 | $2.83M | Sell |
54,982
-50
| -0.1% | -$2.53K | 1.32% | 22 |
|
|
2013
Q4 | $2.91M | Buy |
55,032
+425
| +0.8% | +$20.9K | 1.38% | 22 |
|
|
2013
Q3 | $2.44M | Sell |
54,607
-125
| -0.2% | -$5.54K | 1.29% | 24 |
|
|
2013
Q2 | $2.26M | Buy |
+54,732
| New | +$2.39M | 1.22% | 26 |
|
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
First Bankers Trust's ABBV Position: Q2 2026 in Review
First Bankers Trust increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $1.22M and bringing the position to 37,181 shares worth $9.36M. The position accounts for 2.91% of the portfolio, ranked #4.
First Bankers Trust first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,524 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- First Bankers Trust held 37,181 shares of AbbVie worth $9.36M as of Q2 2026.
- First Bankers Trust bought 5,690 AbbVie shares in Q2 2026, an estimated $1.22M.
- AbbVie made up 2.91% of First Bankers Trust's portfolio in Q2 2026, its #4 holding.
- First Bankers Trust first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 1,524 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on First Bankers Trust's 13F filing for Q2 2026, filed 9 Jul 2026.